グルタミン酸受容体の活性化と無敏感化の構造的メカニズム
Joel R Meyerson1, Janesh Kumar2, Sagar Chittori2
1Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892, USA.
Nature
|August 15, 2014
まとめ
構造的な研究は,AMPAとカイナート受容体のゲーティングがコルクスクリーブの動きとドメインの再編成をどのように含むかを明らかにします. これらの発見は,刺激性神経伝達のためのイオンチャネル機能の重要なステップを説明します.
科学分野:
- 神経科学は神経科学である.
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
背景:
- イオノトロプ的グルタミン酸受容体は,脳内の刺激性シナプス伝達に不可欠である.
- ゲーティングメカニズムを理解することは,神経機能の解読の鍵です.
研究 の 目的:
- AMPAとカイナート受容体におけるイオンフルスゲーティングの構造的基礎を解明する.
- これらの受容体の主要な機能的状態を高解像度で視覚化します.
主な方法:
- クリオ電子顕微鏡を用いて,ネズミのAMPAとカイナート受容体のサブタイプを分析した.
- 受容体は,異なる機能状態 (活性,無感化) に閉じ込められていた.
主要な成果:
- 受容体の活性化には,リガンド結合ドメインの閉塞によって引き起こされるコルクスクリーブの動きが含まれます.
- 脱敏感化は,AMPAとカイナート受容体における異なるアミノ端末ドメインダイナミクスを示している.
- リガンド結合ドメインの対称性トランジションとチャネル閉鎖メカニズムが視覚化されました.
結論:
- グルタミン酸受容体のゲーティングダイナミクスの分子説明を提供します.
- 多様な実験データを統一された構造モデルに統合します.
- イオンチャネル機能と調節に関する洞察を提供します.
関連する概念動画
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Ligand-gated Ion Channels
13.9K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.9K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
Activation and Inactivation of G Proteins
10.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.7K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K


